Tissue diagnostics market is valued at USD 3,202.5 million in 2015 and expected to reach USD 4,471.1 million by 2020, at a CAGR of 6.9% from 2015 to 2020. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in growth rates. A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global tissue diagnostics market and its subsegments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of market players. Estimates of their product segment revenues were validated through primary interviews.
The report also includes company profiles of market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the tissue diagnostics market. The competitive landscape covers the growth strategies adopted by industry players over the last four years. It also includes an analysis of industry developments. The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps the market sizes and growth rates of each subsegment and identifies the segments expected to see rapid growth in each geographic segment.
Browse 76 market data Tables with 96 Figures across 169 Pages and in-depth TOC on " Tissue Diagnostics Market" @ http://www.rnrmarketresearch.com/tissue-diagnostics-market-by-technology-immunohistochemistry-in-situ-hybridization-digital-pathology-workflow-special-staining-disease-breast-cancer-gastric-cancer-lymphoma-prostate-cancer-market-report.html .
The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global tissue diagnostics market in 2015. Asia, on the other hand, is expected to register faster growth during 2015 to 2020. On the basis of technology, this is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. On the basis of diseases, the market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. The key drivers for this market are the increasing prevalence of cancer, growing geriatric population, and growing healthcare expenditure. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market. On the basis of end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users.
For more inquiry on this report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=166792 .
Tissue Diagnostics Market by Technology and Disease
Rising Incidences of Cancer
Rapidly Increasing Aging Population
Growing Healthcare Expenditure
Stringent Regulatory Requirements and Compliance
High Degree of Consolidation
High Growth in Emerging Markets
Increased Use of Personalized Medicine
Increasing Number of Reagent Rental Agreements
The global tissue diagnostics market is segmented based on products, technology, diseases, and end users. On the basis of product, this market is segmented into instruments and consumables. The instruments product segment is further subsegmented into slide-staining systems, scanners, tissue-processing systems, and other instruments. Other instruments include digital pathology systems and histology equipment like automated cover slippers, microtomes, paraffin dispensers, and slide labelers. Consumables product segment is further subsegmented into antibodies, kits, reagents, and probes.
Priced at $4650 for a single user PDF, a sample copy on “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020” research report can be requested at http://www.rnrmarketresearch.com/contacts/request-sample?rname=166792 .
The top leaders in tissue diagnostics market include Abbott Laboratories (U.S.), Agilent Technologies (U.S.), BioGenex Laboratories (U.S.), Bio SB (U.S.), Cell Signaling Technology (U.S.), Danaher Corporation (U.S.), F. Hoffman-La Roche AG (Switzerland), Sigma-Aldrich (U.S.), Thermo Fisher Scientific (U.S.), and Sakura Finetek Japan Co.
(Contact us @ firstname.lastname@example.org / + 1 888 391 5441)
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.